Valtrex Safe-Sex Brochure In Development After Approval For Transmission
Executive Summary
GlaxoSmithKline is creating a patient education brochure to be available in October that will emphasize safe-sex practices with the use of Valtrex
You may also be interested in...
GSK’s Valtrex Clears FDA Cmte.; Herpes Transmission Endpoints Debated
Clinical studies for genital herpes drugs intended to demonstrate a reduction in disease transmission should include seroconversion as a primary endpoint, FDA's Antiviral Drugs Advisory Committee agreed May 14
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials